Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Studies Examine Novel Use For New Oral Anticoagulant Drugs Comment Now Follow Comments
Forbes
Thursday, February 21, 2013 - 11:11am
tags:
anticoagulants, dabigatran, Apixaban
Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
Yahoo
Thursday, February 21, 2013 - 11:09am
tags:
Immune Pharmaceuticals, ulcerative colitis, bertilimumab
Can JAK Inhibitors Challenge Biologics?
Motley Fool
Wednesday, February 20, 2013 - 5:15pm
tags:
JAK inhibitors, Remicade, JNJ, Enbrel, Stelara, Amgen, Humira, AbbVie
Merck, Samsung JV team up on biosimilar medicines
Yahoo/AP
Wednesday, February 20, 2013 - 5:14pm
tags:
Merck, Korea, biosimilars, Samsung Bioepis
Regeneron and Bayer Initiate Phase 3 Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia
Yahoo
Wednesday, February 20, 2013 - 5:12pm
tags:
Bayer, Eyelea, Regeneron, Russia, Asia, DME, diabetic macular edema
Celgene's Fastest-Growing Drug
Motley Fool
Wednesday, February 20, 2013 - 12:16pm
tags:
Celgene, Istodax
InterMune Sale Looms as Lung Drug Nears FDA Nod: Real M&A
Bloomberg
Wednesday, February 20, 2013 - 12:13pm
tags:
FDA, InterMune, M&A, Esbriet
Italian antitrust agency probes alleged Roche-Novartis cartel
Fierce Pharma
Wednesday, February 20, 2013 - 12:12pm
tags:
Lucentis, Roche, Avastin, Italy, Novartis, antitrust
Vertex Pharmaceuticals' Jeffrey Leiden: This Is One Incredible CEO
Motley Fool
Wednesday, February 20, 2013 - 12:11pm
tags:
Vertex Pharmaceuticals, Incivek, Jeffrey Leiden, Pharma CEOs
Almost one-third of chemotherapy used "off-label"
Reuters
Wednesday, February 20, 2013 - 12:08pm
tags:
off-label, chemotherapy
Gilead Settles Teva HIV Drug Patent Suit to Avoid Trial
Bloomberg
Wednesday, February 20, 2013 - 12:05pm
tags:
Teva, patents, HIV, Gilead, Viread, hepatitis B
Pfizer Asks Court To Overturn Generic Injury Ruling
Pharmalot
Wednesday, February 20, 2013 - 11:56am
tags:
generics, Pfizer, Reglan
Novabay: A Novel Agent Against A Common Problem
Seeking Alpha
Wednesday, February 20, 2013 - 11:55am
tags:
NovaBay Pharmaceuticals, NVC-422, antibiotics
Medicines Co.'s 4Q profit grows 5 percent
Yahoo/AP
Wednesday, February 20, 2013 - 11:52am
tags:
Medicines Company, earnings
The War Over Amarin: Feuerstein Battles Heisenberg And How I'd Invest It
Seeking Alpha
Wednesday, February 20, 2013 - 11:51am
tags:
Amarin, Celsion
Allergan’s Botox Put Boy on Respirator, Lawyer Tells Jury
Bloomberg
Wednesday, February 20, 2013 - 11:49am
tags:
Allergan, Botox, misbranding, off-label
Pharmacyclics Valuation Jumps Over $1 Billion On Newest Developments
Seeking Alpha
Wednesday, February 20, 2013 - 11:48am
tags:
Pharmacyclics, JNJ
Elite Pharmaceuticals' CEO Discusses F3Q13 Results - Earnings Call Transcript
Seeking Alpha
Wednesday, February 20, 2013 - 11:47am
tags:
earnings, Elite Pharmaceuticals
A Strong Growth Opportunity In Multiple Sclerosis
Motley Fool
Wednesday, February 20, 2013 - 11:46am
tags:
multiple sclerosis, MS, Elan, Biogen Idec, Tysabri, Teva, XenoPort, Sanofi, BG-12
GlaxoSmithKline Offers A High Dividend, But I Think It's Unsustainable
Seeking Alpha
Wednesday, February 20, 2013 - 11:42am
tags:
dividends, GSK

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.